Allergy, asthma, and the risk of breast and prostate cancer: a Mendelian randomization study

被引：0
|
作者：
Xia Jiang
Niki L. Dimou
Zhaozhong Zhu
Carolina Bonilla
Sarah J. Lewis
Sara Lindström
Peter Kraft
Konstantinos K. Tsilidis
Richard M. Martin
机构：
[1] Harvard T.H. Chan School of Public Health,Program in Genetic Epidemiology and Statistical Genetics
[2] Karolinska University Hospital,Department of Clinical Neurosciences, Karolinska Institute
[3] International Agency for Research On Cancer,Section of Nutrition and Metabolism
[4] University of Bristol,Department of Population Health Sciences, Bristol Medical School
[5] Universidade de São Paulo,Departamento de Medicina Preventiva, Faculdade de Medicina
[6] University of Bristol,MRC Integrative Epidemiology Unit
[7] University of Washington,Department of Epidemiology
[8] Fred Hutchinson Cancer Research Center,Public Health Science Division
[9] Imperial College London,Department of Epidemiology and Biostatistics, The School of Public Health
[10] University of Ioannina School of Medicine,Department of Hygiene and Epidemiology
[11] University Hospitals Bristol NHS Foundation Trust and the University of Bristol,National Institute for Health Research (NIHR) Bristol Biomedical Research Centre
来源：
Cancer Causes & Control | 2020年 / 31卷
关键词：
Mendelian randomization; Malignancy; Breast cancer; Prostate cancer; Asthma; Allergy; Causal inference;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：273 / 282
页数：9
相关论文
共 50 条
  • [21] Cathepsins and cancer risk: a Mendelian randomization study
    Deng, Tingting
    Lu, Xixue
    Jia, Xuemin
    Du, Jinxin
    Wang, Lijuan
    Cao, Baorui
    Yang, Meina
    Yin, Ying
    Liu, Fanjie
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [22] The Causal Effect of Dietary Composition on the Risk of Breast Cancer: A Mendelian Randomization Study
    Dong, Hao
    Kong, Xiangyi
    Wang, Xiangyu
    Liu, Qiang
    Fang, Yi
    Wang, Jing
    NUTRIENTS, 2023, 15 (11)
  • [23] The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study
    Johnson, Kelsey E.
    Siewert, Katherine M.
    Klarin, Derek
    Damrauer, Scott M.
    Program, Va Million Veteran
    Chang, Kyong-Mi
    Tsao, Philip S.
    Assimes, Themistocles L.
    Maxwell, Kara N.
    Voight, Benjamin F.
    PLOS MEDICINE, 2020, 17 (09)
  • [24] The role of preeclampsia in breast cancer risk: insights from Mendelian randomization study
    Qian, Chenfei
    Xiong, Ganwei
    Hong, Shihao
    Miao, Linzhe
    Guo, Yitao
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [25] Identification of circulating metabolites linked to the risk of breast cancer: a mendelian randomization study
    Zhu, Xiaosheng
    Huang, Huai
    Zou, Mengjie
    Luo, Honglin
    Liu, Tianqi
    Zhu, Shaoliang
    Ye, Bin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [26] Diabetes mellitus and prostate cancer risk: A mendelian randomization analysis
    Yuan, Jian-Xu
    Jiang, Qing
    Yu, Sheng-Jie
    WORLD JOURNAL OF DIABETES, 2023, 14 (12)
  • [27] Lipid metabolite levels associated with the risk of breast cancer: a Mendelian randomization study
    Zhang, W.
    Zhao, D.
    Huang, H.
    Uddin, H.
    Zhang, Y.
    Yang, H.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 116 - 117
  • [28] Asthma and risk of adverse pregnancy outcomes: A Mendelian randomization study
    Han, Xinyu
    Wu, Tian qiang
    Bian, Yuanyuan
    Chen, Lu
    Feng, Xiaoling
    HELIYON, 2024, 10 (13)
  • [29] Association of asthma with the risk of cardiovascular disease: A Mendelian randomization study
    Han, Shuang
    Wu, Xiao
    Peng, Xiufa
    Zhang, Chunling
    EXPERIMENTAL GERONTOLOGY, 2024, 195
  • [30] Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study
    Dimou, Niki L.
    Papadimitriou, Nikos
    Gill, Dipender
    Christakoudi, Sofia
    Murphy, Neil
    Gunter, Marc J.
    Travis, Ruth C.
    Key, Tim J.
    Fortner, Renee T.
    Haycock, Philip C.
    Lewis, Sarah J.
    Muir, Kenneth
    Martin, Richard M.
    Tsilidis, Konstantinos K.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (03) : 807 - 816
12345